Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Breast Cancer Research
Published in: Breast Cancer Research 2/2006

01-11-2006 | Poster Presentation

Development of anti-MUC1 DNA aptamers for the imaging and radiotherapy of breast cancer

Authors: C Da Pieve, JN Iley, A Perkins, S Missailidis

Published in: Breast Cancer Research | Special Issue 2/2006

Login to get access

Excerpt

Aptamers are novel oligonucleotide-based recognition molecules which can bind to almost any target, including extracellular proteins, antibodies, peptides and small molecules. Aptamers can be rapidly generated, and offer reduced immunogenicity, good tumour penetration, rapid uptake and clearance, and can thus be used as alternatives to monoclonal antibodies in molecular targeted radiotherapy and diagnostic imaging. …
Metadata
Title
Development of anti-MUC1 DNA aptamers for the imaging and radiotherapy of breast cancer
Authors
C Da Pieve
JN Iley
A Perkins
S Missailidis
Publication date
01-11-2006
Publisher
BioMed Central
Published in
Breast Cancer Research / Issue Special Issue 2/2006
Electronic ISSN: 1465-542X
DOI
https://doi.org/10.1186/bcr1587

Other articles of this Special Issue 2/2006

Breast Cancer Research 2/2006 Go to the issue

Poster Presentation

Development of small-molecule transforming growth factor beta antagonists

Oral Presentation

Breast cancer susceptibility after BRCA1/2: finding the genes and potential practical applications

Poster Presentation

Expression of adrenomedullin in long-term oestrogen-deprived human breast cancer cells

Oral Presentation

Novel roles for integrins in tumour angiogenesis

Oral Presentation

BRCA1 transcriptionally regulates genes associated with the basal breast cancer phenotype

Oral Presentation

Evolution of aromatase inhibitors as an endocrine treatment for breast cancer
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits